Subjects eat food from a plate that sits on a scale connected to a computer that records the weight loss of the plate during the meal and makes up a curve of food intake, meal duration and rate of eating modeled by a quadratic equation. The purpose of the method is to change eating behavior by providing visual feedback on the computer screen that the subject can adapt to because her/his own rate of eating appears on the screen during the meal. The data generated by the method is automatically analyzed and fitted to the quadratic equation using a custom made algorithm. The method has the advantage of recording eating behavior objectively and offers the possibility of changing eating behavior both in experiments and in clinical practice. A limitation may be that experimental subjects are affected by the method. The same limitation may be an advantage in clinical practice, as eating behavior is more easily stabilized by the method. A treatment that uses this method has normalized body weight and restored the health of several hundred patients with anorexia nervosa and other eating disorders and has reduced the weight and improved the health of severely overweight patients.
Introduction
The device presented here is used to restore the body weight and the health of under-and overweight patients by controlling the rate of eating and the intake of food via visual feedback provided on a computer screen during the meal. It consists of a custom made electronic scale and a computer, e.g., a smartphone. An app allows a subject to connect the smartphone to the scale via Bluetooth. Once the smartphone is connected to the scale, the subject puts a plate on the scale and food on the plate and starts eating. At regular intervals, a rating scale appears on the screen and the subject is asked to rate her/his feeling of fullness. The rating scale can be disconnected, depending upon the aim of the experiment or the clinical intervention. For experimental and clinical purposes a reference curve for eating rate and a reference curve for the feeling of fullness are displayed on the screen of the smartphone. The subject can adapt to the reference curves because her/his rate of eating and ratings of fullness appear on the screen during the meal.
The device records the decrease of the weight of the plate as food is consumed and the ratings of fullness over the course of the meal and stores the recordings. The weight loss data are used to yield a quadratic model of the cumulative food intake (CFI) curve: y=kx 2 +lx, where y=amount of food consumed, k=change in the rate of eating over the course of the meal and l=initial rate of eating 1 . The CFI curve is based on modelling the following three actions during the meal: bite, food addition, and artifact (weight changes unrelated to food consumption). These actions are mapped on non-terminal symbols of a context-free grammar (CFG) 2 . The recording, after pre-processing, is partitioned into time intervals corresponding to weight changes (based on forward derivative and delta coefficients), which are then mapped to CFG terminal symbols. The CFG then allows estimation of the most likely interpretation of the meal assuming independence for each event.
The device is used in research as well as in clinical practice. It was first used to treat patients with anorexia nervosa and other eating disorders and subsequently to treat severely overweight patients.
Eating assisted by visual feedback has the following scientific basis. Animals, including humans, have evolved to eat many different foods, but they select what to eat under "buffet" conditions . However, it is unlikely that the hundreds of millions of people in the world, who now weigh too much 9 , developed the problem because of a neural abnormality before the weight gain. It is more likely that neural abnormalities 10 , as well as medical abnormalities 11 , develop as an effect of eating too much 12 , save, perhaps in some rare genotypes 13 .
A possible reason why neuroscience fails to explain the problems of body weight is because its basic assumption is incorrect, i.e., that body weight is kept nearly constant via excitatory/inhibitory neural controls exerted over eating behavior 8 . Whatever inhibition the brain may exert has obviously not prevented hundreds of millions of people to become seriously overweight recently 9 . A better understanding of the role of brain in eating emerged from the discovery that hypothalamic peptides once thought to stimulate eating act instead to permit the search for food, even at the expense of food intake 14, 15 . These results, which were confirmed recently 16, 17 , support the view that body weight is kept at a healthy level only when the physical price of food is high, a condition referred to as "the human homeostatic phenoptype" 18 . Considering the multiplicity of brain and genetic networks engaged in eating behavior and other behaviors also 19 , it would be difficult, if at all possible, to decrease or increase body weight by manipulating a neurotransmitter system or two. Given these consideration, it comes as no surprise that pharmacological intervention has minimal, or no effects on body weight in the seriously overweight 20 , as well as in the underweight 21 .
It is ironic that some of these recent findings merely confirm the predictions concerning the role of diets, genes, brain, and physical activity in body weight regulation made by Mayer in 1953 already 22 . As an alternative, eating behavior may have a causal role in the control of body weight and neuroscience and genetics may have mistaken mechanism for cause. In support, daily eating over the year strives to maximize food intake in humans, pushing body weight upwards to counteract any influence of food shortage 23 . In the human homeostatic phenotype, the influence of this kind of physiological overeating is counterbalanced by the physical effort needed to obtain food 18 . Because that effort is close to zero today humans need external support to maintain a healthy low body weight. That support is provided by the present device.
Rather than targeting eating behavior, standard treatments for eating disorders target the patients´ psychological symptoms. On average 30% of the patients drop out of these treatments, fewer than 50% go into remission, although they remain symptomatic, and at least 30% relapse within one year of discharge 24 . However, it was found long ago that treating eating behavior has a better effect than treating the psychological symptoms 25 . This finding was replicated more recently by using the device described in this report. By this method, an estimated 75% of patients with eating disorders go into remission and 10% relapse over five years of follow-up 26 , an improvement over standards of care 24 .
Although the rate of eating has increased in seriously overweight patients, the cause-effect relationship among rate of eating and body weight has not been clarified and the rate of eating has been determined by questionnaires 27 . The device described here makes objective measurement of eating rate and food intake possible and when used to reduce these two measures, it has been demonstrated to be more effective in decreasing body weight and improving health than standard diet and exercise intervention in severely overweight adolescents 28 .
The principle of recording eating behavior utilized in the present device was described long ago 29, 30, 31 , and it has since then been used in experiments to record and change the rate of eating 1, 6, 7, 32, 33 . However, it has not been used to treat under-and overweight patients outside of clinical trials and in clinical practice. Part of the clinical program involves using the device at home and in everyday life. It has proven to be user friendly in both laboratory research and in clinical practice. 
Discussion
While the method described here is a major intervention in our treatment of patients with problems of body weight, the treatment has additional interventions, which have been described before, including criteria for admission and remission 34 and outcome at three months intervals in each of 1428 patients 26 . The device, not these additional interventions, is the focus of the present report.
The Control mode of the device is used to record eating behavior in healthy subjects and in under-and overweight patients. The Training mode is subsequently used to change eating behavior for experimental or clinical purposes. Using visual feedback in the treatment of anorexic patients, 100% as indicated on the computer screen, is the amount of food the patient should eat determined individually on the basis of three preliminary tests in the Control mode. 100% is a small amount of food in an anorexic patient, but more food than s/he ate in the three preliminary tests. An anorexic patient pratices eating progressively more food, and s/he is asked to add food until 100% is indicated on the screen. The shape of the dashed blue reference curve, which remains the same over the course of treatment, is based on the finding that normal weight healthy people eat at a progessively decreasing rate, i.e., in a decelerated manner 1 . The dashed purple reference curve for the feeling of fullness is based on the finding that the cumulative satiety curve is best fitted to a sigmoid curve 1 . There are no numbers on the axes. The treatment continues until the patient is able to eat about 300-350 g of food in about 10-15 min without a reference curve. These data were obtained from normal weight, healthy subjects. Both under-and overweight patients have a choice between three dishes of ordinary Swedish food in clinical pratice and they are offered water to drink. Experimental manipulation of eating behavior is done in the same manner in healthy subjects 1, 6, 7, 32, 33 . Because re-establishing the normal feeling of fullness using the visual feedback provided by a reference curve is done in the same manner it is not discussed here. Clinically, however, this is an important intervention as anorexic patients rate the feeling of fullness much higher than do healthy subjects.
While patients follow the visual feedback when eating in treatment, they are allowed to add food to the plate during the meal when they eat without feedback. Food additions and other events, including pressure exterted on the plate during sectioning of the food using forks and knives, affect the recording by the device creating artifacts and errors that were previously dealt with manually as described in from eating using the device is collected in a custom made database, from which the clinician can retrieve the results for providing patients with feeback on how treatment progresses and the researcher can use for analysing experimental results.
Anorexic patients eat only little food at a slow rate 34 . Interestingly, however, they are able to consume normal sized meals even at very low BMI 18 . For example, the patient reported was able to eat 300 g very early in treatment and long before normalization of her BMI and a mere three days after eating in a disordered manner, i.e., consuming only little food at an accelerating rate. Anorexic patients who start eating at an extremely low rate are likely to increase the rate of eating over the course of the initial meals, as did three of the patients reported here. When patients approach remission, however, the inverse relationship among the rate of deceleration and the initial rate of eating emerges 1 . Several hundred patients with eating disorders have been treated to remission and the protocol has proven user friendly with no adverse side effects 26 . Severely obese patients have been similarly treated to lose weight, albeit not to a normal weight 28, 33 . At present there is no method that normalizes the body weight of severely overweight patients.
A limitation of the method is that subjects are likely affected by the device even in the absence of visual feedback. That hypothesis can be tested by comparing data obtained with the device with data obtained from video-recorded meals. Paradoxically, the same limitation may be an advantage in treatment, which aims at normalizing food intake.
While the present method has long been used to record eating behavior, the addition of visual feedback for experimental and clinical purposes has not been used outside our research and clinic. For clinicians aiming at restoring the eating behavior of the patients and for scientists interested in using eating behavior as an experimental variable, the device offers a method. The analysis of the results can now be automated using the present algorithm for computing the CFI curve, alleviating the need for time-consuming manual processing. This makes monitoring and analysis of eating behavior in large groups of subjects possible.
The effectiveness of the algortihm will be further improved. At present it is based on estimations of deviations from true values of bites as dissociated from artifacts.
The device will be used among children to prevent problems of body weight in adulthood. Most of the hardware and software discussed in this report are ready for such large scale use. Possible improvements, including optimizing the visual design of feedback on the screen of the device and expanding the CFG with additional kinds of in-meal actions and the analysis of partially completed meals, must await the outcome of the intended large scale use.
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